Schrappe, M., & Bartram, C. R. (2018). Reduced-intensity delayed intensification in standard-risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000). Journal of clinical oncology, 36(3), . https://doi.org/10.1200/JCO.2017.74.4946
Chicago-Zitierstil (17. Ausg.)Schrappe, Martin, und Claus R. Bartram. "Reduced-intensity Delayed Intensification in Standard-risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000)." Journal of Clinical Oncology 36, no. 3 (2018). https://doi.org/10.1200/JCO.2017.74.4946.
MLA-Zitierstil (9. Ausg.)Schrappe, Martin, und Claus R. Bartram. "Reduced-intensity Delayed Intensification in Standard-risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000)." Journal of Clinical Oncology, vol. 36, no. 3, 2018, https://doi.org/10.1200/JCO.2017.74.4946.